Brief: Newbury Pharmaceuticals Secures Generic Approval For Mirtazapin Newbury
24/10/2025 07:35
Oct 24 (Reuters) - Newbury Pharmaceuticals AB NEWBRY.ST: NEWBURY PHARMACEUTICALS SECURES GENERIC APPROVAL FOR MIRTAZAPIN NEWBURY RECEIVES MARKETING AUTHORIZATION IN SWEDEN Source text: ID:nMFN76GQP0 Further company coverage: NEWBRY.ST (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 772 0920;))
Recent news on Newbury Pharmaceuticals AB
See all newsBrief: Newbury Secures Hospital Portfolio Rights In Iraq
Brief: Newbury Signs Licence And Supply Deal For Guanfacine
Brief: Newbury Pharmaceuticals Gets Approval for Tofacitinib Newbury
Brief: Newbury Pharmaceuticals Secures Generic Approval For Dalbavancin Newbury
Brief: Newbury Pharmaceuticals Reports Q3 EBITDA Of SEK -4 Mln